0 CHECKOUT

Gingivitis - Pipeline Review, H1 2015

  • ID: 3330532
  • June 2015
  • 37 pages
  • Global Markets Direct
1 of 4

Gingivitis - Pipeline Review, H1 2015

Summary

This, ‘Gingivitis - Pipeline Review, H1 2015’, provides an overview of the Gingivitis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Gingivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gingivitis and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Gingivitis Overview
Therapeutics Development
Pipeline Products for Gingivitis - Overview
Pipeline Products for Gingivitis - Comparative Analysis
Gingivitis - Therapeutics under Development by Companies
Gingivitis - Therapeutics under Investigation by Universities/Institutes
Gingivitis - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Gingivitis - Products under Development by Companies
Gingivitis - Products under Investigation by Universities/Institutes
Gingivitis - Companies Involved in Therapeutics Development
Biomedical Development Corporation
Stemnion, Inc
VivaCell Biotechnology Espana S.L.
Gingivitis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Amnion Derived Cellular Cytokine Solution - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BLXA-4ME - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CDE-001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Iocide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Mul-1867 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gingivitis - Recent Pipeline Updates
Gingivitis - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Gingivitis, H1 2015
Number of Products under Development for Gingivitis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Gingivitis - Pipeline by Biomedical Development Corporation, H1 2015
Gingivitis - Pipeline by Stemnion, Inc, H1 2015
Gingivitis - Pipeline by VivaCell Biotechnology Espana S.L., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Gingivitis Therapeutics - Recent Pipeline Updates, H1 2015
Gingivitis - Dormant Projects, H1 2015

List of Figures
Number of Products under Development for Gingivitis, H1 2015
Number of Products under Development for Gingivitis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Biomedical Development Corporation
Stemnion, Inc
VivaCell Biotechnology Espana S.L.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Nobel Biocare Holding AG
  • 3M Company
  • Centrix Inc.
  • California Dental Association
  • Midmark Corporation
  • Saint-Gobain S.A.